6 July 2021
Sintra, 30th June 2021 – Labatec inaugurated its first factory in Portugal, in the presence of the Secretary of State for Internationalization, Eurico Brilhante Dias, the Infarmed Vice President, António Faria Vaz, the Swiss Ambassador to Portugal, André Regil and the Mayor of Sintra, Basílio Horta. The project started in January 2018, and three years later, after […]
9 June 2021
LABATEC WOMEN HEALTH AND MITHRA ANNOUNCE THE SUCCESSFUL LAUNCH OF MYLOOP® IN SWITZERLAND A hormonal contraceptive ring Geneva, 10th of June 2021 – LABATEC successfully launches a contraceptive vaginal ring – MyLoop® manufactured by our partner Mithra. About MyLoop® This contraceptive vaginal ring is a generic of NuvaRing®. This medicine will be marketed as MyLoop®, […]
3 June 2020
Swissmedic approves Intrarosa® (prasterone) for the treatment of vulvovaginal atrophy in postmenopausal women A novel drug for the treatment of vulvovaginal atrophy based on prasterone (DHEA) Geneva, the 02.06.2020 – On 19.05.2020, Swissmedic, the Swiss Agency for Therapeutic Products, granted a marketing authorization for the active substance prasterone for the local treatment of vulvovaginal […]
29-01
October
2021
Interlaken, Switzerland
25-27
November
2021
Interlaken, Switzerland
9-11
November
2021
Milan, Italy
Would you like to discuss a collaboration or partnership project? Get in touch with us at partnering@labatec.com or connect with us at one of the upcoming events.
For other enquiries, please visit our contact page.